Purdue Pharma owners strike new $6.5 billion deal in opioid case
The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.
View original article
Contributor: David Ovalle, Mark Johnson
